Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
ursodeoxycholic acid | aldo-keto reductase family 1 member c2 | small molecule | NA | drugbank , DGIDB | Biliary calculi[MeSHID:D042882] Cholecystolithiasis[MeSHID:D041761] Operative Surgical Procedures[MeSHID:D013514] Cholelithiasis[MeSHID:D002769] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Primary biliary cirrhosis[MeSHID:D008105] |
NA | approved,investigational | inducer |
ursodeoxycholic acid | biliverdin reductase a | NA | Successful target | TTD , DGIDB | Biliary calculi[MeSHID:D042882] Cholecystolithiasis[MeSHID:D041761] Operative Surgical Procedures[MeSHID:D013514] Cholelithiasis[MeSHID:D002769] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Primary biliary cirrhosis[MeSHID:D008105] |
NA | approved | unknown |
ursodeoxycholic acid | bile acid receptor | small molecule | NA | drugbank | Biliary calculi[MeSHID:D042882] Cholecystolithiasis[MeSHID:D041761] Operative Surgical Procedures[MeSHID:D013514] Cholelithiasis[MeSHID:D002769] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Primary biliary cirrhosis[MeSHID:D008105] |
NA | approved,investigational | unknown |
ursodeoxycholic acid | solute carrier family 23 member 2 | NA | Successful target | TTD , DGIDB | Biliary calculi[MeSHID:D042882] Cholecystolithiasis[MeSHID:D041761] Operative Surgical Procedures[MeSHID:D013514] Cholelithiasis[MeSHID:D002769] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Primary biliary cirrhosis[MeSHID:D008105] |
NA | approved | unknown |
click here to return to the previous page |